Progynova

PreclinicalSmall molecule

UUniversitair Ziekenhuis Brussel

Progynova is one of 7 small molecule programs targeting Tranexamic Acid. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Tranexamic AcidUnknown status

Tranexamic AcidPreclinical

Unknown status

Competition

Competitive Landscape

6 competitors in Tranexamic Acid

#DrugCompanyPhaseTrials

Cyklokapron

JJ Molner

Approved

156 2

Pitressin

AAultman Health Foundation

Approved

3 3

Tranexamic Acid Pill

HHenry Ford Health System

Phase 3

1 4

IV TXA

MMassachusetts General Hospital

Phase 3

1 5

Adrenaline

AARS Pharmaceuticals, Inc.

Preclinical

2 6

Progynova

UUniversitair Ziekenhuis Brussel

Preclinical

1 7

IV Atropine

AAssiut University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tranexamic Acid1 trial

Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users

Unknown status·DDepartment of Medical Services Ministry of Public Health of Thailand·N/A·NCT06067217·52 enrolled

Elective1 trial

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

Completed·UUniversitair Ziekenhuis Brussel·N/A·NCT02148393·212 enrolled

Infertility (IVF Patients)1 trial

Comparison Between Oral Estradiol 8 mg Versus 12 mg for Endometrial Preparation in Programmed Frozen Embryo Transfer Cycles on Clinical Pregnancy Rate: A Double-Blind Randomized Controlled Trial

Completed·CCairo University·Approved·NCT07526207·850 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Progynova. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Progynova compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Progynova. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universitair Ziekenhuis Brussel company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversitair Ziekenhuis Brussel

Progynova

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Tranexamic Acid1 trial

Elective1 trial

Infertility (IVF Patients)1 trial

References

Drug Info

Quick Facts

Related News